On Invalid Date, Ac Immune Sa (NASDAQ: ACIU) reported Q4 2023 earnings per share (EPS) of -$0.06, up 75.71% year over year. Total Ac Immune Sa earnings for the quarter were -$5.65 million. In the same quarter last year, Ac Immune Sa's earnings per share (EPS) was -$0.25.
As of Q1 2024, Ac Immune Sa's earnings has grown year over year. Ac Immune Sa's earnings in the past year totalled -$61.63 million.
What is ACIU's earnings date?
Ac Immune Sa's earnings date is Invalid Date. Add ACIU to your watchlist to be reminded of ACIU's next earnings announcement.
What was ACIU's revenue last quarter?
On Invalid Date, Ac Immune Sa (NASDAQ: ACIU) reported Q4 2023 revenue of $17.62 million up 1,638,991.91% year over year. In the same quarter last year, Ac Immune Sa's revenue was $1.08 thousand.
What was ACIU's revenue growth in the past year?
As of Q1 2024, Ac Immune Sa's revenue has grown 316.44% year over year. This is 150.83 percentage points higher than the US Biotechnology industry revenue growth rate of 165.61%. Ac Immune Sa's revenue in the past year totalled $16.82 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.